Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2019

Dec 31, 2019

30583_dirs_2019-12-30_dc7835f3-c521-48a6-b9e8-4469f64f9eb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-12-03

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-26 Common Stock M 3000 $21.51 Acquired 330530 Direct
2019-12-26 Common Stock S 3000 $86.43 Disposed 327530 Direct
2019-12-27 Common Stock M 5000 $21.51 Acquired 332530 Direct
2019-12-27 Common Stock S 5000 $86.16 Disposed 327530 Direct
2019-12-03 Common Stock G 630 Disposed 180261 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-26 Stock Option (Right to buy Common Stock) $21.51 M 3000 Disposed 2020-05-11 Common Stock (3000) Direct
2019-12-27 Stock Option (Right to buy Common Stock) $21.51 M 5000 Disposed 2020-05-11 Common Stock (5000) Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on June 11, 2019.

F2: On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by increasing the total amount of securities beneficially owned by the reporting person by such 450 shares.

F3: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

F4: Trade made pursuant to a 10b5-1 plan executed on September 6, 2019.

F5: On December 3, 2019 the reporting person gifted 630 shares to a charitable organization.

F6: On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by decreasing the total amount of securities beneficially owned by the reporting person's trust by such 450 shares.

F7: Reflects the number of options outstanding after the transactions from this specific stock option grant.